Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2008-07-15
2008-07-15
Foley, Shanon A. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C424S257100
Reexamination Certificate
active
07399474
ABSTRACT:
Compositions comprising products of the csa operon, an isolated nucleic acid encoding the csa operon or functional fragments thereof, purified polypeptide products of the csa operon or functional fragments thereof, methods of eliciting an immune response to these products, and methods of producing products of the csa operon are disclosed herein.
REFERENCES:
patent: 4946778 (1990-08-01), Ladner et al.
patent: 5417986 (1995-05-01), Reid et al.
patent: 5932715 (1999-08-01), Scott et al.
patent: 6110898 (2000-08-01), Malone et al.
patent: 6187344 (2001-02-01), Eljamal et al.
patent: 6190669 (2001-02-01), Noriega et al.
patent: WO 96 38171 (1996-12-01), None
Greenspan et al. (Nature Biotechnology 7: 936-937, 1999).
Cruse et al., Illustrated Dict. of Immunology, 2nd ed., CRC Press, 2003, p. 46.
McGuinness et al. (Mol. Microbiol., 7:505-514, 1993).
Moudallal et al. (EMBO Journal, 1:1005-1010, 1982.
Freedman et al,J. Infect. Disease, 177:662-667 (1998).
Levine et al,Infect. Immun., 23:729-736 (1979).
Altboum et al,Infect. Immun., 71:1352-1360 (2003).
Cancer WEB Online Medical Dictionary, “Gene Product” (2002).
Scott et al,Mol. Micro., 6(3):293-300 (1992).
Watson et al, Recombinant DNA, Scientific America Books, N.Y. (1992).
Altboum et al, Construction of a Bivalent Shigella-ETEC Vaccine Expressing CS2 and CS3 Pili, Abstract, 99thGeneral Meeting of the American Society for Microbiology, 99:293 (1999).
Altboum et al, Construction of a Bivalent Shigella-ETEC Vaccine Expressing CS4 Pili, Abstract, 100thGeneral Meeting of the American Society for Microbiology, 100:303 (2000).
Koprowski et al, Construction and Analysis of a Shigella Flexneri 2a/CFA/I Vaccine, Abstract, 99thGeneral Meeting of the American Society for Microbiology, 99:293 (1999).
Holger et al,J. of Bacteriology, 181(11):3578-3581 (1999).
Hinxton, Database EBI “online”, Van Dijk, United Kingdom (May 7, 1996).
Altboum et al,Infect. Immun., 69(5):3150-3158 (2001).
Black et al,Bulletin of the World Organization, 59(2):263-268 (1981).
Black,Reviews of the Infect. Dis., 8(2):S131-S135 (1986).
Blomfield et al,Mol. Microbiology, 5(6):1447-1457 (1991).
Bolivar et al.Gene, 2:95-113 (1977).
Chang et al,Nature, 275:617-624 (1978).
Cote et al,Proc. Natl. Acad. Sci., 80:2026-2030 (1983).
deHaan et al,FEMS Microbiology Letters, 83:341-346 (1991).
DuPont et al,New England J. of Med., 295(27):1520-1521 (1976).
Duthy et al,J. of Bacteriology, 181(18):5847-5851 (1999).
deBoer et al,Proc. Natl. Acad. Sci., 80:21-25 (1983).
Engvall et al,Meth. Enzymol., 70:419-439 (1980).
Felgner et al,Proc. Natl. Acad. Sci., 84:7413-7417 (1987).
Fraley et al, TIBS, 6:77-80 (1981).
Froelich et al,Mol. Microbiology, 12(3):387-401 (1994).
Lodish et al,Mol. Cell Biol., Third Ed., pp. 252-254, Scientific American Books, Inc. (1995).
Frolich et al,Infect. and Immunity, 63(12):4849-4856 (1995).
Gaastra et al,Trends in Microbiology, 4(11):444-452 (1996).
Galen et al,Infection and Immunity, 67(12):6424-6433 (1999).
Goeddel et al,Nature, 281:544-548 (1979).
Goeddel et al,Nucleic Acids Research, 8(18):4057-4075 (1980).
Grewal et al,Vaccine, 11(2):221-226 (1993).
Hall et al,J. of Bacteriology, 171(11):6372-6374 (1989).
Hamers et al,Microbiol Pathogenesis, 6:297-309 (1989).
Hitzeman et al,J. of Biological Chemistry, 255(24):12073-12080 (1980).
Holland et al,Biochemistry, 17(23):4900-4907 (1978).
Huse et al,Science, 246:1275-1281 (1989).
Hyams et al,The New England Journal of Medicine, 325(20):1423-1428 (1991).
Jalajakumari et al,Mol. Microbiology, 3(12):1685-1695 (1989).
Jaye et al,Nucleic Acids Res., 11(8):2325-2335 (1983).
Jertborn et al,Vaccine, 16(2/3):255-260 (1998).
Knutton et al,Infect. Immun., 57(11):3364-3371 (1989).
Kohler et al,Nature, 256:495-497 (1975).
Koprowski et al,Infect. Immun., 68(9):4884-4892 (2000).
Kotloff et al,Vaccine, 13(5):495-502 (1995).
Levine et al,Infect. Immun., 44(2):409-420 (1984).
Levine,J. of Infect. Dis., 155(3):377-389 (1987).
Levine,Journal of Pediatric Gastroenterology and Nutrition, 31:336-355 (2000).
Manning et al,Mol. Gen. Genet., 200:322-327 (1985).
Mannino et al,BioTechniques, 6(7):682-690 (1988).
Maxam et al,Methods in Enzymology, 65:499-561 (1980).
McConnell et al,Infection and Immunity, 56(8):1974-1980 (1980).
McConnell et al,FEMS Microbiology Letters, 61:105-108 (1989).
McConnell et al,Epidermiol. Infect., 106:477-484 (1991).
Merson et al,The New England Journal of Medicine, 294(24):1299-1305 (1976).
Riffkin et al,Gene, 167:279-283 (1995).
Messing et al,Nucleic Acids Research, 9(2):309-321 (1981).
Morrison et al,Proc. Natl. Acad. Sci., 81:6851-6855 (1984).
Neuberger et al,Nature, 312:604-608 (1984).
Noriega et al,Infect. and Immunity, 64(1)23-27 (1996).
Orlandi et al,Proc. Natl. Acad. Sci., 86:3833-3837 (1989).
Qadri et al,J. of Clinical Microbiology, 38(1):27-31 (2000).
Rudin et al,Microbial Pathogenesis, 16:131-139 (1994).
Rudin et al,Microbial Pathogenesis, 20:35-45 (1996).
Rudin et al,Epidemiol. Infect., 119:391-393 (1997).
Sakellaris et al,Molecular Microbiology, 30(4):681-687 (1998).
Sakellaris et al,PNAS, 96(22):12828-12832 (1999).
Savalkoul et al,Microbial Pathogenesis, 8:91-99 (1990).
Siebenlist et al,Cell, 20:269-281 (1980).
Sommerfelt et al,Microbial Pathogenesis, 11:297-304 (1991).
Sommerfelt et al,J. of Clinical Microbiology, 30(7):1823-1828 (1992).
Sommerfelt et al,Infect. and Immunity, 60(9):3799-3806 (1992).
Svennerholm et al,Infect. and Immunity, 56(2):523-528 (1988).
Takeda et al,Nature, 314:452-454 (1985).
Thomas et al,J. of General Microbiology, 131:2319-2326 (1985).
Vaitukaitis et al,J. Clin. Endocr., 33:988-991 (1971).
Viboud et al,Microbial Pathogenesis, 21:139-147 (1996).
Wallace et al,Nucleic Acids Research, 9:879-895 (1981).
Willshaw et al,FEMS Microbiology Letters, 49:473-478 (1988).
Willshaw et al,FEMS Microbiology Letters, 68:255-260 (1990).
Willshaw et al,FEMS Microbiology Letters, 82:125-130 (1991).
Winter et al,Nature, 349:293-299 (1991).
Wolf et al,Infection and Immunity, 57(1):164-173 (1989).
Wolf et al,FEMS Microbiology Letters, 148:35-42 (1997).
Bowie et al,Science, 247(4948):1306-1310 (1990).
Abaza et al,J. Protein Chem., 11(13):433-444 (1992).
Altboum et al. Construction of a bivalentShigella-ETEC vaccine expressing CS2 and CS3 pili. Abstract E-113. Abstracts of the 99thGeneral Meeting of the American Society for Microbiology, May 30, 1999 (available electronically on or about Apr. 25, 1999).
Altboum et al. Construction of bivalentShigella-ETEC vaccine expressing CS4 pili, Abstract E-46. Abstracts of the 100thGeneral Meeting of the American Society for Microbiology, May 21, 2000 (available electronically on or about Apr. 16, 2000).
Altboum Zeev
Barry Eileen M.
Levine Myron M.
Foley Shanon A.
Gangle Brian J
University of Maryland Baltimore
LandOfFree
Isolation and characterization of the csa operon (ETEC-CS4... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isolation and characterization of the csa operon (ETEC-CS4..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolation and characterization of the csa operon (ETEC-CS4... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2807336